Insider trading activities remain a focal point in the financial sector, with executives and institutional investors actively adjusting their portfolios. Tower Research Capital LLC TRC made a notable move by increasing its holdings in Centene Co. by 369.9% during the 4th quarter, signaling confidence in the healthcare provider. Five9, Inc.’s EVP Panos Kozanian parted with 6,893 shares, while Cetera Advisor Networks LLC upped its stake in Invesco S&P 500 Quality ETF by a significant 539.4%. Angeles Wealth Management LLC and Epoch Investment Partners Inc. have also been active, with the former increasing its shares in Vanguard Total World Stock ETF and the latter making substantial investments in Eli Lilly and Company and Bruker Co..Conversely, Epoch Investment Partners Inc. has reduced its holdings in Linde plc, Fortinet, Inc., and AbbVie Inc., reflecting a strategic shift in their investment approach. These transactions are set against a backdrop of varying stock performances and new analyst ratings, underscoring the dynamic nature of market investments. Insider sales have been disclosed in compliance with SEC regulations, offering transparency into the financial decisions of those at the helm of major companies.
Key points
- Tower Research Capital LLC TRC significantly increased its stake in Centene Co.
- Insider trading activities, including sales by Five9, Inc.
- Epoch Investment Partners Inc.
, indicating a strong investment interest.
‘s EVP and purchases by Cetera Advisor Networks LLC, demonstrate active portfolio management.
has notably adjusted its holdings in several companies, both increasing and decreasing stakes in key sectors.
